Actively Recruiting
Prevention of Emergence Agitation in Rhinoplasty With Subanesthetic Propofol and Single-Dose Dexmedetomidine: A Prospective Double-Blind Clinical Study
Led by Yuzuncu Yil University · Updated on 2025-08-27
80
Participants Needed
1
Research Sites
41 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To compare of prevention of emergence agitation in rhinoplasty with subanesthetic propofol and single dose dexmedetomidine
CONDITIONS
Official Title
Prevention of Emergence Agitation in Rhinoplasty With Subanesthetic Propofol and Single-Dose Dexmedetomidine: A Prospective Double-Blind Clinical Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients scheduled for rhinoplasty
- Aged between 18 and 65 years
- Classified as ASA I or II
You will not qualify if you...
- Younger than 18 or older than 65 years
- ASA classification III or above
- Presence of kidney, liver, heart, or lung diseases
- Known allergy to study medications
- History of urinary catheterization
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Van Yüzüncü Yıl University
Van, Tuşba, Turkey (Türkiye), 65100
Actively Recruiting
Research Team
M
Mehmet Emin Keskin, assistant professor
CONTACT
B
Bedrettin Bingöl, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here